Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury

Detalles Bibliográficos
Autores principales: Teixiera, J., Atta, M.G., Noureddine, L., Nguyen, S., O’Rourke, B., Tilles, A., Bornschlegl, S., LaPointe, E., Dietz, A., Nissenson, A., Blair, A., Parekkadan, B., Barcia, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111903/
http://dx.doi.org/10.1016/S1465324921002772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111903/
http://dx.doi.org/10.1016/S1465324921002772

Ejemplares similares